Scientific Steering Committee 2017

Speakers’ presentations

14th December 2017

  1. Introduction – Carlo Giaquinto
  2. EPIICC update and next steps – Ali Judd
  3. Update ongoing trials: Odyssey – Anna Turkova
  4. Update on ongoing trials – Anna Turkova
  5. Smile update 2017 – Alex Compagnucci
  6. New trials opportunities – Pablo Rojo
  7. EPIICAL update and future steps – Paolo Palma
  8. NeoAMR/PedAMR – Mike Sharland
  9. ECRAID and other European antimicrobial initiatives – Theo Zaoutis
  10. The fungal future – Adilia Warris
  11. Is there any question for a paediatric clinical trial? – Giuseppe Indolfi
  12. How to use the existing networks for other studies – Claire Thorne
  13. PENTA-ID in GAPf positioning the network in a complex global initiative – Martina Penazzato
  14. PENTA-ID communications objectives strategies and tools – Francesca Mazzetto
  15. PENTA Data management – Andrea Oletto
  16. PENTA – Data management – Paolo Sacerdoti
  17. PENTA regulatory affairs – Alessandra Nardone
  18. PENTA capacity development – Davide Bilardi

 

15th December 2017

  1. Discussion about non-industry driven trial proposals coming from the PENTA-ID Network: C4C presentation by L. Mangiarini, EURO CORTEEC, KD-CAAP, Aspergillus in CF, PADO Platform
  2. Work programme 2018-2020 interesting topics for the Network – Carlo Giaquinto
  3. Beyond HIV – Steve Welch
  4. Acceptability presentation – Marck Lallemant
  5. The next step of the PENTAvac group the MenBhiv Study – Paolo Palma
  6. PCV13 in HIV infected children: An antigen to remember– Vana Spoulou
  7. PediCAP trial– Mike Sharland
  8. Empirical – Pablo Rojo
  9. PENTA-ID identity – Rebecca Lundin